Tape wird geladen…Tape wird geladen…
RVMD
RVMD
Indizes, Rohstoffe, Movers, Heatmap und Top-Stories. Ohne Login.
Indizes, Rohstoffe, Movers, Heatmap und Top-Stories. Ohne Login.
RVMD
RVMD NASDAQ
Revolution Medicines to Report Financial Results for Third Quarter 2026 After Market Close on November 4, 2026
Revolution Medicines Begins Phase 3 Trial For Advanced Lung Cancer Treatment
Revolution Medicines Begins Treating Patients in Phase 3 RASolve 308 Trial Evaluating Zoldonrasib in Combination with Pembrolizumab and Chemotherapy as First-Line Treatment for Patients with Metastatic RAS G12D Non-Squamous Non-Small Cell Lung Cancer
7,403 Shares in Revolution Medicines, Inc. $RVMD Purchased by SteelPeak Wealth LLC
3,373 Shares of Revolution Medicines, Inc. $RVMD Bought by First Citizens Bank & Trust Co.
Revolution Medicines Stock Has Surged 124% This Year — Analyst Sees More Room to Grow
Umsatz & Nettogewinn (5J)
EPS & Wachstum (5J)
Free Cash Flow (5J)
Kapitalrendite
Operating- & Nettomarge (5J)
CapEx vs. Free Cashflow (5J)
Kapitalallokation (5J)
F&E- und SG&A-Intensität (5J)
EBITDA (5J)
Umsatzkosten (5J)
Marktkapitalisierung (5J)
Frag Blinx mit professionellen Marktdaten, Charts neben dem Chat und deinem Depot-Kontext.
Standard sind Lang & Schwarz Kurse. NASDAQ ist der verzögerte Listing-Kurs. Charts bleiben Tageskurse. Keine Anlageberatung.